ATOZET EZETIMIBE-ARTOVASTATIN

$190.70

Category:

Description

ATOZET EZETIMIBE-ARTOVASTATIN

Primary hypercholesterolemia

ATOZET is indicated as an adjunct to diet for the reduction of elevated total cholesterol (total-C), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and lipoprotein cholesterol. non-high-density (non-HDL-C) and to increase high-density lipoprotein cholesterol (HDL-C) in patients with primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed hyperlipidemia.

Homozygous Familial Hypercholesterolemia (HoFH)

ATOZET is indicated for the reduction of elevated levels of total-C and LDL-C in patients with HoFH. Patients may also receive adjuvant treatments

ATOZET EZETIMIBE-ARTOVASTATIN

Reviews

There are no reviews yet.

Be the first to review “ATOZET EZETIMIBE-ARTOVASTATIN”

Your email address will not be published. Required fields are marked *

Scroll to top
We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept